Порівняльний аналіз асортименту лікарських засобів для фармакотерапії дитячого церебрального паралічу в Україні та за Британським Національним Формуляром

Олена Вікторівна Парамош

doi:10.15587/2519-4852.2016.79680

Authors

Олена Вікторівна Парамош Lviv National Medical University named Daniel Galicki Pekarskaya str., 69, Lviv, Ukraine, 79010, Ukraine https://orcid.org/0000-0002-0339-395X

DOI:

https://doi.org/10.15587/2519-4852.2016.79680

Keywords:

pharmaceutical care at the children’s cerebral palsy, medications range, patients with the children’s cerebral palsy pharmacotherapy

Abstract

Aim. The improvement of the range of medicines applied for the cerebral palsy treatment in Ukraine.

Metthods. System analysis, marketing research, expert estimation of remedies.

Results. Pharmacuetical market of Ukraine needs to be expanded by including the actual remedies for the cerebral palsy treatment: Oxcarbazepine from the antiepileptic remedies pharmacotherapeutic group and Atomoxetine from the group of the psycoanaleptics, which are being used in British lists. Four muscle relaxants, available in the British children's formulary: Xeomin, Azalyur, Bocautur and Damdrolene Sodium are absent in Ukraine.

Conclusion. 34 drugs from the Ukraine State drug formulary (2016), State drug register (2016), the British children's formulary (April, 2016), and the British national formulary (April, 2016) as common objects for the study of the modern range of medicines in developed countries, were analyzed for comparative study of pharmaceutical market of remedied applied for the cerebral palsy treatment.

The differential analysis by specific pharmacological groups is presented by muscle relaxants, which include 8 remedies, antiepileptic drugs – 12, psychoanaleptics – 12, and other remedies affecting nervous system – 2. To compare, antiepileptic drug Oxcarbazepine and Atomoxetine from the group of the psycoanaleptics are absent in Ukraine. Muscle relaxants: Suxamethonium, Pipekuroniyu bromide, Tolperizon, and psychoanaleptics that are not included into the British formularies: Caffeine, Vinpocetine, Mebicar, Phenybutun are used in Ukraine simultaneously

Author Biography

Олена Вікторівна Парамош, Lviv National Medical University named Daniel Galicki Pekarskaya str., 69, Lviv, Ukraine, 79010

PhD, Associate Professor

Department of organization and economics of pharmacy, medicine and pharmacoeconomics technology

References

Nakaz «Pro zatverdzhennja Koncepcii' rozvytku farmacevtychnogo sektoru galuzi ohorony zdorov’ja Ukrai'ny na 2011–2020 roky» (2010). MOZ Ukrai'ny, 769. Available at: http://www.moz.gov.ua/ua/portal/dn_20100913_769.html
Nakaz «Galuzeva programa standartyzacii' medychnoi' dopomogy na period do 2020 roku» (2011). MOZ Ukrai'ny, 597. Available at: http://www.moz.gov.ua/ua/portal/dn_20110916_597.html
Martynenko, Ja. A. (2016). Epidemiologichna struktura zahvorjuvanosti ditej na cerebral'nyj paralich. Simejna medycyna. Perspektyvy ta shljahy podal'shogo rozvytku. Kompleksnyj pidhid do pytan' reabilitacii'. Novitni tendencii' likuvannja ta profilaktyky dermatovenerologichnyh problem v ramkah dokazovoi' medycyny. Lviv, 63–64.
Azars'kyj, I. M., Azars'ka, O. O. (2002). Dytjachyj cerebral'nyj paralich, nadbana slabkorozumovist' ta pedagogichna zanedbanist': Social'no-reabilitacijni aspekty dlja hvoryh v suspil'stvi. Khmelnyc: VAT "Vyd-vo "Podillja", 159.
Moisejenko, R. O., Sokolovs'ka, Ja. I., Kul'chyc'ka, T. K., Buhanovs'ka, T. M. (2010). Analiz ta tendencii' zahvorjuvanosti dytjachogo naselennja Ukrai'ny. Sovremennaja pedyatryja, 3 (31), 13–17.
Orlova, N. M. (2011). Medyko-social'ne obg'runtuvannja restrukturyzacii' merezhi ambulatorno-poliklinichnyh zakladiv iz vrahuvannjam medyko-demografichnyh osoblyvostej regioniv. Kyiv, 396.
Gorachuk, V. V. (2014). Medyko-social'ne obguntuvannja modeli systemy upravlinnja jakistju medychnoi' dopomogy. Kyiv, 391.
Paramosh, O. V. (2008). Optymizacija likars'kogo zabezpe-chennja hvoryh z rozladamy psyhiky. Lviv, 21.
Avedisova, A. S., Ahapkin, R. V., Ahapkina, V. I., Verigo, N. I. (2001). Analiz zarubezhnyh issledovanij nootropnyh preparatov (na primere piracetama). Ros. psihiatr. zhurn., 1, 46–53.
Spysok neefektyvnyh likiv. Available at: http://topfiles.timedosuga.com/?p=9031
Jakovljeva, L. V., Rybka, A. V. (2013). Cerebroprotekcija v aspekti dokazovoi' medycyny: cerebrolizyn ta piracetam. Upravlinnja, ekonomika ta zabezpechennja jakosti v farmacii', 5, 59–65. Available at: http://nbuv.gov.ua/UJRN/Uezyaf_2013_5_11